Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

• 主要な著者: Sruamsiri Rosarin (著者), Chaiyakunapruk Nathorn (著者), Pakakasama Samart (著者), Sirireung Somtawin (著者), Sripaiboonkij Nintita (著者), Bunworasate Udomsak (著者), Hongeng Suradej (著者)
• フォーマット: 図書
• 出版事項: BMC, 2013-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Hematopoieticic stem cell transplantation is the only therapeutic option that can cure thalassemia disease. Reduced intensity hematopoietic stem cell transplantation (RI-HSCT) has demonstrated a high cure rate with minimal complicati...